SCHEMBL6353295

SCHEMBL6353295

Cc1nn(-c2ccccn2)c2[nH]c3c(c(=O)c12)CCCC3

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.54
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
THRB P10828 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
HSD17B10 Q99714 1/20 0.39
CCNA2 P20248 6/20 0.39
CDK2 P24941 6/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA3 P34903 1/20 0.38
CCNO P22674 1/20 0.38
CCNE1 P24864 1/20 0.38
CCNA1 P78396 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6342483 0.99 PARP1 (0.53) PARP1ALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL6351972 0.77 MAPT (0.41) PARP1ALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL6339985 0.76 L3MBTL1 (0.43) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6354095 0.76 L3MBTL1 (0.40) PARP1ALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL6354124 0.74 MAPT (0.41) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6344742 0.73 MAPT (0.39) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6340087 0.73 MAPT (0.42) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6343219 0.73 L3MBTL1 (0.40) ALDH1A1MAPTSMN1; SMN2THRBTDP1
SCHEMBL6341115 0.73 MEN1 (0.45) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL6344842 0.72 SPR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 PARP1 3752/4885ALDH1A1 1061/4885MAPT 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.